© 2021 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2021 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
Tony Hagen is senior managing editor for The Center for Biosimilars®.
March 06, 2021
Minnesota legislators introduce what could possibly become the first law to curtail payers' rights to determine which biologics patients have access to.
March 04, 2021
Investigators evaluated trial spending and reasons for biologics license application failures.
March 02, 2021
Biocon and Viatris edge closer to EU marketing authorization for a bevacizumab biosimilar, among other biosimilar business developments.
March 01, 2021
The National Comprehensive Cancer Network (NCCN) recommended providers contact their legislators to counteract single-biosimilar payer policies.